Accelerated Approval: Makena Real-World Evidence Insufficient To Verify Clinical Benefit, CDER Says

 
• By Sue Sutter

Covis seeks to discuss study proposals and other accelerated approval precedents at still-unscheduled withdrawal hearing; CDER says company’s current RWE proposal is inadequate given its design and the failure of the PROLONG confirmatory clinical trial.

Door closed
CDER has closed the door on any bid by Covis to rely solely on real-world evidence to confirm Makena's clinical benefit. • Source: Alamy

More from Real-World Evidence

More from Clinical Trials